Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unknown

10.6084/m9.figshare.10278767Source: DataRank Database

Unknown is a research paper. On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

Linked data & code

MOESM6 of Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer · figshare

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (23)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Live enrichment

PubMed:19965766 OpenAlex:https://openalex.org/W4394387803

National Institutes of Health

Grant: 2K12CA001727-16A1

City of Hope Clinical Oncology Career Research Development Program

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

greenLicense: cc-by

repositoryhttps://doi.org/10.6084/m9.figshare.10278767

https://dx.doi.org/10.6084/m9.figshare.10278767.v1

https://dx.doi.org/10.6084/m9.figshare.10278767

Fields of Study

Cancer Treatment and PharmacologyAdvanced Breast Cancer TherapiesCancer therapeutics and mechanismsFOS: Biological sciencesFOS: Health sciences03 medical and health sciences0302 clinical medicine

Keywords

Space ScienceMedicineGeneticsPharmacologyBiological Sciences not elsewhere classifiedInformation Systems not elsewhere classifiedCancerInfectious DiseasesEribulinTriple-negative breast cancerTriple negativeEverolimusMetastatic breast cancerOncologyInternal medicineBreast cancer

MOESM6 of Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer

10.6084/m9.figshare.10278767.v1figshare

Unknown

FAIR Checklist

Funding (2 grants)

Open Access

Topics

Linked Datasets (1)